Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity

Clinical and Experimental Ophthalmology

Volumn 42, Issue 5, 2014, Pages 459-465

  Gunn, David J ^a   Cartwright, David W ^b,c   Gole, Glen A ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Laser; Prematurity; ROP

Indexed keywords

ANTIBIOTIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; STEROID;

AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; COHORT ANALYSIS; EYE FIXATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFANT DISEASE; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; MEDICAL RECORD REVIEW; NEWBORN INTENSIVE CARE; OPHTHALMIC DIODE LASER; OUTCOME ASSESSMENT; PREVALENCE; RETROLENTAL FIBROPLASIA; VISION; VISUAL ACUITY; VITRECTOMY; EXTREMELY LOW BIRTH WEIGHT; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTERIOR EYE SEGMENT; PREMATURITY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURGERY; TREATMENT OUTCOME;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, EXTREMELY PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LASER COAGULATION; MALE; POSTERIOR EYE SEGMENT; PREVALENCE; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84904737414     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12280     Document Type: Article

References (35)

1. Fanaroff AA, Stoll BJ, Wright LL etal. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196: 147. e1-8.
2. Allegaert K, de Coen K, Devlieger H. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol 2004; 88: 239-242.
3. Austeng D, Kallen KB, Ewald UW, Jakobsson PG, Holmstrom GE. Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol 2009; 127: 1315-1319.
4. Gunn DJ, Cartwright DW, Gole GA. Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol 2012; 40: 93-99.
5. Clark D, Mandal K. Treatment of retinopathy of prematurity. Early Hum Dev 2008; 84: 95-99.
6. Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 2002; 109: 936-941.
7. Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 2002; 109: 928-934. Discussion p 35.
8. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 2001; 132: 76-80.
9. Yang CM, Chen MS, Tsou Yau KI, Teng RJ. Comparison of cryotherapy and laser photocoagulation in stage III retinopathy of prematurity. J Formos Med Assoc 1997; 96: 734-739.
10. Soejima N, Takagi I, Takashima Y. Clinical studies on retinopathy of prematurity, severe and rapidly progressive type. Folia Ophthalmol Jpn 1976; 27: 155-161.
11. Uemura Y, Tsukahara I, Nagata M. Diagnostic and therapeutic criteria for retinopathy of prematurity. Committee's Report Appointed by the Japanese Ministry of Health and Welfare Tokyo, Japan Japanese Ministry of Health and Welfare 1974.
12. An International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-999.
13. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121: 1684-1694.
14. Palmer EA, Hardy RJ, Dobson V etal. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005; 123: 311-318.
15. Axer-Siegel R, Maharshak I, Snir M etal. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina 2008; 28: 839-846.
16. Drenser KA, Trese MT, Capone A, Jr. Aggressive posterior retinopathy of prematurity. Retina 2010; 30: S37-40.
17. Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina 2006; 26: S11-15.
18. O'Keefe M, Lanigan B, Long VW. Outcome of zone 1 retinopathy of prematurity. Acta Ophthalmol Scand 2003; 81: 614-616.
19. Soh Y, Fujino T, Hatsukawa Y. Progression and timing of treatment of zone I retinopathy of prematurity. Am J Ophthalmol 2008; 146: 369-374.
20. Gunn DJ, Cartwright DW, Yuen SA, Gole GA. Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol 2013; 41: 159-166.
21. Lee GA, Hilford DJ, Gole GA. Diode laser treatment of pre-threshold and threshold retinopathy of prematurity. Clin Experiment Ophthalmol 2004; 32: 164-169.
22. The Committee for the Classification of Retinopathy of Prematurity. An International Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984; 102: 1130-1134.
23. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1988; 106: 471-479.
24. Ells AL, Gole GA, Lloyd Hildebrand P, Ingram A, Wilson CM, Geoff Williams R. Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity. Eye (Lond) 2013; 27: 525-530.
25. Axer-Siegel R, Bourla D, Friling R etal. Intraocular pressure variations after diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 2004; 111: 1734-1738.
26. Zin A, Gole GA. Retinopathy of prematurity - incidence today. Clin Perinatol 2013; 40: 185-200.
27. Repka MX, Tung B, Good WV, Capone A, Jr, Shapiro MJ. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol 2011; 129: 1175-1179.
28. Azuma N, Ishikawa K, Hama Y, Hiraoka M, Suzuki Y, Nishina S. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol 2006; 142: 636-643.
29. Nishina S, Yokoi T, Kobayashi Y, Hiraoka M, Azuma N. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography. Ophthalmology 2009; 116: 2442-2447.
30. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364: 603-615.
31. Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE. Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2013; 98: F170-174.
32. Spandau U, Tomic Z, Ewald U, Larsson E, Akerblom H, Holmstrom G. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity. Acta Ophthalmol 2013; 91: 170-175.
33. The Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251g. Arch Ophthalmol 2002; 120: 595-599.
34. Good WV, Hardy RJ, Dobson V etal. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol 2010; 128: 663-671.
35. Recsan Z, Vamos R, Salacz G. Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2003; 40: 204-207.